Showing results (111-120 of 213) with videos related to

Sort By:
Pageof 22
American Journal of Clinical Oncology|June 6, 2019
Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon CancerJulie L Koenig, Diego A S Toesca, Jeremy P Harris, et al.
Rare Tumors|February 23, 2012
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old maleStephen M Wanta, Marina Basina, Steven D Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2020
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinomaDiego A S Toesca, Faisal Ahmed, Mehr Kashyap, et al.
Nature Communications|March 26, 2021
Predicting treatment response from longitudinal images using multi-task deep learningCheng Jin, Heng Yu, Jia Ke, et al.
Cancer|January 2, 2009
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasDaniel T Chang, Devin Schellenberg, John Shen, et al.
Practical Radiation Oncology|March 10, 2017
Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PETDiego A S Toesca, Erqi L Pollom, Peter D Poullos, et al.
Annals of Surgical Oncology|September 27, 2023
Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant RadiationCaressa Hui, Agnes Ewongwo, Brianna Lau, et al.
Expert Review of Anticancer Therapy|September 4, 2014
Stereotactic body radiation therapy in pancreatic cancer: the new frontierShalini Moningi, Ariel E Marciscano, Lauren M Rosati, et al.
Cancer|July 29, 2010
Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinomaDaniel T Chang, Christopher H Chapman, Jeffrey A Norton, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 28, 2011
HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessmentPamela L Kunz, Amirkaveh Mojtahed, George A Fisher, et al.
Pageof 22